SEARCH

SEARCH BY CITATION

References

  • 1
    Lynn J, Harrell FE, Cohn F, et al: Defining the “Terminally 111”: Insights from SUPPORT. Duq L Rev 1996; 35: 311336.
  • 2
    Field MJ, Cassel CK (eds): Approaching Death: Improving Care at the End of Life. Committee on Care at the End of Life, Institute of Medicine, National Academy Press, Washington DC, 1997
  • 3
    American Society of Clinical Oncology. Cancer Care During the Last Phase of Life, J Clin Oncol 1998; 16: 19861996.
  • 4
    MacDonald N: The interface between oncology and palliative medicine, in Doyle D, Hanks GWC, MacDonald N (eds). Oxford Textbook of Palliative Medicine, 2nd Edition, New York, Oxford University Press, 1998, p 11.
  • 5
    Saunders, CM: Living with Dying: The management of terminal disease, Vol 1. Oxford University Press, Oxford, New York, 1983.
  • 6
    Twycross RG, Lack SA: Therapeutics in Terminal Cancer, Churchill Livingstone, New York, 1984.
  • 7
    Twycross, RG: Symptom control: The problem area. Pall Med, 1993; 7: (suppl 1) 18.
  • 8
    Levy M: Pharmacologic treatment of cancer pain. N Engl J Med 1996; 335: 11241132.
  • 9
    Truog RD, Berde CB, Mitchell C, Grier, HE: Barbiturates in the care of the terminally ill. N Engl J Med 1992; 327: 16781681.
  • 10
    Greene WR, Davis WH: Titrated intravenous barbiturates in the control of symptoms in patients with terminal cancer. So Med J 1991; 84: 332337.
  • 11
    Byock, IR: Consciously walking the fine line: Thoughts on a hospice response to assisted suicide and euthanasia. J Pal Care 1993; 9: 2528.
  • 12
    National Hospice Organization. Standards of a Hospice Program of Care, The Hospice Journal, 1994; 9: 3974.
  • 13
    Cancer Pain Relief and Palliative Care. Technical Report Series 804. Geneva, World Health Organization, 1990, p 11.
  • 14
    Byock IR: The nature of suffering and the nature of opportunity at the end of life. Clin Ger Med. 1996; 12: 237252.
  • 15
    Precepts of Palliative Care. Task Force on Palliative Care, Last Acts Campaign, Robert Wood Johnson Foundation, J Pall Med 1998; 1: 109112.
  • 16
    National Hospice Organization Standards and Accreditation Committee. A Pathway for Patients and Families Facing Terminal Disease. Arlington, VA: NHO, 1997.
  • 17
    Christakis A, Escarce E: Survival of medicare patients after enrollment in hospice programs. N Engl J Med 1996; 335: 172178.
  • 18
    Kinzbrunner BM: Hospice: 15 years and beyond in the care of the dying. J Pall Med 1998; 1: 127137.
  • 19
    Anders G: U.S. Cracks Down on Hospices Treating Patients Who Aren't on Brink of Death. Wall Street Journal, January 8,1997.
  • 20
    Babcock, CR: Hospices Big Business, Thanks to Medicare Exploitation of Some Patients Is Alleged, Washington Post, June 14,1998.
  • 21
    Fraud and Abuse in Nursing Home Arrangements with Hospices. Special Fraud Alert, Office of the Inspector General, Department of Health and Human Services, March 1998.
  • 22
    Medicare Hospice Beneficiaries. Services and Eligibility, Office of the Inspector General, Department of Health and Human Services, OEI-04–93–00270, April 1998.
  • 23
    Davie K: Press Release, National Hospice Organization, April 21, 1998.
  • 24
    Schonwetter RS, Soendker S, Perron V, et al: Review of Medicare's proposed hospice eligibility criteria for select noncancer patients, Am J Hospice Pall Care 1998; 15: 155158.